Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: Induction by interleukin-1

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 1977-1984

  Cronauer, Marcus Victor ^a,b,c   Stadlmann, Sylvia ^a   Klocker, Helmut ^b   Abendstein, Burghard ^a   Eder, Iris Elisabeth ^b   Rogatsch, Hermann ^a   Zeimet, Alain Gustave ^a   Marth, Christian ^a   Offner, Felix Albert ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR;

ARTICLE; CELL ADHESION; CYTOKINE RELEASE; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESOTHELIUM CELL; PERITONEAL CAVITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032762319     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65516-2     Document Type: Article

References (51)

1. Runyon BA Surgical peritonitis and other diseases of the peritoneum, mesentery, omentum, and diaphragm. Gastrointestinal Disease. Edited by MH Sleisenger JS Fordtran. Philadelphia, Saunders, 1993, pp 2004-2014
2. Carter D, True L, Otis CN: Serous membranes. Histology for Pathologists. Edited by SS Sternberg. New York, Lippincott-Raven, 1997, pp 2299-2328
3. Topley N, Petersen MM, Mackenzie R, Neubauer A, Stylianou E, Kaever V, Davies M, Coles GA, Jörres A, Williams JD: Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 1994, 46:900-909
4. Topley N: The cytokine network controlling peritoneal inflammation. Perit Dial Int 1995, 15(suppl) 35-40
5. Yung S, Thomas GJ, Stylianou E, Williams JD, Coles GA, Davies M: Source of peritoneal proteoglycans: human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfale proteoglycans. Am J Pathol 1995, 146:520-529
6. Ikubo A, Morisaki T, Katano M, Kitsuki H, Anan K, Uchiyama A, Tanaka M, Torisu M: A possible role of TGF-β in the formation of malignant effusions. Clin Immunol Immunopathol 1995, 77:27-32
7. Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF: Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling and stroma formation in the peritoneal lining. Cancer Res 1995, 55:376-385
8. Zeimet AG, Marth C, Offner FA, Obrist P, Uhl-Steidl M, Feichtinger H, Stadlmann S, Daxenbichler G, Dapunt O: Human per toneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Gynecol Oncol 1996, 62:384-389
9. Lanfrancone L, Boraschi D, Gniara P, Falini B, Grignani F, Peri G, Mantovani A, Peliccir PG: Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor (CSF), granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 (IL-1), and IL-6 and are activated and stimulated to grow by IL-1. Blood 1992, 80:2835-2842
10. Topley N, Brown Z, Joerres A, Westwick J, Davies M, Coles GA, Williams JD: Human peritoneal mesothelial cells synthesize interleukin-8: synergistic induction by interleukin-1β and tumor necrosis factor-α. Am J Pathol 1993, 142:1876-1886
11. Topley N, Joerres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, Muller C, Coles GA, Davies M., Williams JD: Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1β and TNF-α. Kidney Int 1993, 43:226-233
12. Davila RM, Crouch EC: Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury. Am J Pathol 1993, 142:547-555
13. Douvdevani A, Rapoport J, Konforty A, Agrov S, Ovnat A, Chaimovitz C: Human peritoneal mesothelial cells synthesize IL-1α and β. Kidney Int 1994, 46:993-1001
14. Offner FA, Obrist P, Stadlmann S, Feichtinger H, Klinger P, Herold M, Zwierzina H, Hittmair A, Mikuz G, Abendstein B, Zeimet A, Marth C: IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 1995, 7:542-547
15. Zeimet AG, Widschwendtner M, Knabbe C, Fuchs D, Herold M, Mueller-Holzner E, Daxenbichler G, Offner FA, Dapunt O, Marth C: Ascitic IL-12 is an independent prognostic factor in ovarian cancer: J Clin Oncol 1998, 16:1861-1868
16. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-β 1 gene results in multilocal inflammatory disease. Nature 1992, 359: 693-699
17. Offner FA, Feichtinger H, Obrist P, Marth, Klingler P, Grage B, Schmahl M, Knabbe C: Transforming growth factor-β synthesis by human peritoneal mesothelial cells - induction by interleukin-1 Am J Pathol 1996, 148:1679-1688
18. Saksela O, Moscatelli D, Ritkin DB: The opposing effects of basic fibroblast growth factor and transforming growth factor β on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 1987, 105:957-963
19. Sato Y, Rifkin DB: Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement plasminogen activator synthesis, and DNA synthess. J Cell Biol 1988, 107:1199-1205
20. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB: Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells regulation of plasminogen activator activity. J Cell Biol 1992, 118:901-909
21. Phillips AO, Topley N, Morrisey K, Williams JD, Steadman R: Basic fibroblast growth factor stimulates the release of preformed transforming growth factor β1 from human proximal tubular cells in absence of de novo gene transcription or mRNA translation. Lab Invest 1997, 76 591-600
22. Shinozaki M, Kawara S, Hayashi N, Kakinuma T, Igarashi A, Takehara, K: Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor β: simultaneous application with basic fibroblast growth factor causes persistent fibrosis. Biochem Biophys Res Commun 1997, 227:292-296
23. Burgess WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989, 58:575-606
24. Bikfalvi A, Klein S, Pintucci G, Rifkin DB: Biological roles of fibroblast growth factor-2. Endocr Rev 1997, 18:26-45
25. McKeehan WL, Wang F, Kan M: The heparin sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol 1998, 59:135-176
26. Faham S, Linhardt RJ, Rees DC: Diversity does make a difference: fibroblast growth factor-heparin interactions. Curr Opin Struct Biol 1998, 8:578-586
27. Ohbayashi N, Hoshikawa M, Kimura S, Yamasaki M, Fukui S, Itoh N: Structure and expression of the mRNA encoding a novel fibroblast growth factor, FGF-18. J Bio Chem 1998, 273:18161-18164
28. Gospodarowicz D, Cheng J: Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 1986, 128:475-484
29. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodawski I: A heparin binding angiogenic protein, basic fibroblast growth factor is stored within the basement membrane. Am J Pathol 1988, 130: 393-400
30. Rifk n DB, Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989, 109:1-6
31. Vlodavsky I, Miao HQ, Medalion B, Dangher P, Ron D: Involvement of heparan sulfate and reated molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metast Rev 1996, 15:177-186
32. Cronauer MV, Hittmair A, Eder IE, Hobisch A, Culig Z, Ramoner R, Zhang J, Bartsch G, Reissigl A, Radmayr C, Thurnher M, Klocker H: Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate 1997, 31:223-233
33. Montesano R, Vassalli JD, Baird A, Guilemin R, Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986, 83:7297-7301
34. Buckley-Sturrock A, Woodward SC, Senior RM, Griffin GL, Klagsburn M, Davidson JM: Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J Cell Physiol 1989, 138:70-78
35. Friesel RE, Maciag T: Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995, 9:919-925
36. Offner FA, Wirtz HC, Schiefer J, Bigalke I, Klosterhalfen B, Bittinger F, Mittermayer C, Kirkpatrick CJ: Interaction of human malignant melanoma (ST-ML-12) tumor spheroids with endothelial cell monolayers: damage to endothelium by oxygen-derived radicals. Am J Pathol 1992, 141:601-610
37. Schmidt A, Skaletz-Rorowski A, Breithardt G, Budeckke E: Growth status-dependent changes of bFGF compartmentalization and heparan sulfate structure in arterial smooth muscle cells. Eur J Cell Biol 1995, 67:130-134
38. Schmidt A, Skaletz-Rorowski A, Budeckke E: Basic fibroblast growth factor controls the expression and molecular structure of heparansulfate in corneal epithelial cells. Eur J Biochem 1995, 234:479-484
39. Culig Z, Klocker H, Eberle J, Kaspar F, Hobisch A, Cronauer MV, Bartsch G: DNA sequence of androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 1993, 21:11-22
40. Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G, Klocker H: Expression of transforming growth factors β-1, β 2 and β 3 in human bladder carcinomas. Br J Cancer 1997, 75:1753-1760
41. Mignatti P, Morimoto T, Rifkin DB: Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci USA 1991, 88:11007-11011
42. Yu QC, McNeil PL: Transient disruptions of aortic endothelial cell plasma membranes. Am J Pathol 1992, 141:1349-1360
43. Mignatti P, Morimoto T, Ritkin DB: Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmatic reticulum-Golgi complex. J Cell Physiol 1992, 151:81-93
44. Vlodavsky I, Bar-Shavit R, Isahai-Michaeli R, Bashkin P, Fuks Z: Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci 1991, 16:268-271
45. Kurita Y, Tsuboi R, Ueki R, Rifkin DB, Ogawa H: Immunhistochemical localization of basic fibroblast growth factor in wound healing sites of mouse skin. Arch Dermatol Res 1992, 284:193-197
46. Ohtani H, Nakamura S, Watanabe Y, Mizoi, T, Saku, T, Nagura, H: Immunohistochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 1993, 68:520-527
47. Friess H, Yamanaka Y, Buchler M, Berger HG, Do DA, Kobrin MS, Kork M: Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 1994, 144:117-128
48. Mutsaers SE, McAnulty RJ, Laurent GJ, Versnel MA, Whitaker D, Papadimitriou JM: Cytokine regulation of mesothelial cell proliferation in vitro and in vivo. Eur J Cell Biol 1997, 72:24-29
49. Hasebe T, Imoto S, Ogura T, Mukai K: Significance of basic fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast. Jpn J Cancer Res 1997, 88:877-885
50. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rikin DB, Mignatti P: Fibroblast growth factor-2 induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 1998, 141:1659-1673
51. Williams RS, Rossi AM, Chegini N, Schultz G: Effect of transforming growth factor β on postoperative adhesion formation and intact peritoneum. J Surg Res 1992, 52:65-70